RxDoctor Payments Data

Jose Diaz, DO

Physical Medicine & Rehabilitation · Ft Lauderdale, FLNPI 1164535753

Payments from drug & device makers

$2,786in general payments, 2019–2025

Across 164 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$911
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$433
  • AbbVie$381
  • Scilex Pharmaceuticals Inc.$277
  • Valinor Pharma, LLC$192
  • Redhill Biopharma Inc.$165
  • plus $427 from 8 others

What the payments were for

  • Food & beverage$2,786100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,786 in reported general payments places this provider in the 85th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$301,729
Medicare patients
139
Services billed
7,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl353$565,158
Xtampza ErOxycodone Myristate217$162,482
MovantikNaloxegol Oxalate176$79,552
Oxycodone Hcl942$31,341
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen466$23,040
Fentanyl118$16,821
BotoxOnabotulinumtoxina11$15,168
Morphine Sulfate ErMorphine Sulfate308$10,766
LinzessLinaclotide11$6,921
Gabapentin393$4,500
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen125$3,418
Pregabalin195$3,334
Hydromorphone ErHydromorphone Hcl24$3,118
Metaxalone14$2,918
Hydromorphone Hcl70$2,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$911$162,482217 claims
Redhill Biopharma Inc.Movantik$165$79,552176 claims
AbbVieBotox, Linzess$381$22,08822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 618 physical medicine & rehabilitation providers in Florida.

Other physical medicine & rehabilitation in Ft Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →